Dr. Imran Haque, M.D

NPI: 1134107022
Total Payments
$18,695
2024 Payments
$2,409
Companies
87
Transactions
1,120
Medicare Patients
101,926
Medicare Billing
$7.9M

Payment Breakdown by Category

Food & Beverage$18,428 (98.6%)
Education$267.37 (1.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $18,428 1,107 98.6%
Education $267.37 13 1.4%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $2,420 107 $0 (2024)
ABBVIE INC. $1,492 106 $0 (2024)
Lilly USA, LLC $1,406 98 $0 (2024)
Novo Nordisk Inc $1,265 107 $0 (2024)
Novartis Pharmaceuticals Corporation $1,047 55 $0 (2024)
Janssen Pharmaceuticals, Inc $742.10 52 $0 (2024)
Alkermes, Inc. $671.10 26 $0 (2024)
Teva Pharmaceuticals USA, Inc. $652.14 32 $0 (2024)
Sunovion Pharmaceuticals Inc. $579.27 30 $0 (2020)
Merck Sharp & Dohme LLC $505.36 35 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,409 132 ABBVIE INC. ($461.73)
2023 $2,441 132 Alkermes, Inc. ($355.82)
2022 $2,810 154 AstraZeneca Pharmaceuticals LP ($314.62)
2021 $2,296 141 AbbVie Inc. ($401.78)
2020 $2,249 125 AstraZeneca Pharmaceuticals LP ($677.69)
2019 $2,627 175 AstraZeneca Pharmaceuticals LP ($398.53)
2018 $1,825 112 Novartis Pharmaceuticals Corporation ($282.50)
2017 $2,038 149 AstraZeneca Pharmaceuticals LP ($419.34)

All Payment Transactions

1,120 individual payment records from CMS Open Payments — Page 1 of 45

Date Company Product Nature Form Amount Type
12/19/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $27.93 General
Category: Central Nervous System
12/18/2024 Eisai Inc. Leqembi (Drug) Food and Beverage In-kind items and services $13.92 General
Category: Neurology
12/09/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $15.81 General
Category: Inflammation
12/02/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $15.79 General
Category: Cardiology/Vascular Diseases
11/21/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $18.15 General
Category: Central Nervous System
11/19/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $13.68 General
Category: NEUROSCIENCE
11/13/2024 Vanda Pharmaceuticals Inc. HETLIOZ (Drug), FANAPT Food and Beverage In-kind items and services $17.00 General
Category: NON-24-HOUR SLEEP-WAKE DISORDER
11/12/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $11.74 General
Category: NEUROSCIENCE
11/11/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $28.98 General
Category: Diabetes
11/07/2024 Corcept Therapeutics Korlym (Drug) Food and Beverage In-kind items and services $19.44 General
Category: Endocrinology
11/07/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $19.37 General
Category: Respiratory
11/06/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $22.85 General
Category: NEUROSCIENCE
11/04/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $23.59 General
Category: GASTROENTEROLOGY
11/04/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $13.16 General
Category: Cardiology/Vascular Diseases
10/28/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $14.51 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/27/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $8.16 General
Category: Diabetes
10/24/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $16.40 General
Category: Central Nervous System
10/21/2024 SANOFI-AVENTIS U.S. LLC TZIELD (Biological) Food and Beverage In-kind items and services $24.70 General
Category: Endocrine & Metabolic Diseases
10/17/2024 Neurelis, Inc. VALTOCO (Drug) Food and Beverage In-kind items and services $21.15 General
Category: EPILEPSY
10/16/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $21.15 General
Category: NEUROSCIENCE
10/14/2024 Vanda Pharmaceuticals Inc. HETLIOZ (Drug), FANAPT Food and Beverage In-kind items and services $15.00 General
Category: NON-24-HOUR SLEEP-WAKE DISORDER
10/09/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $22.20 General
Category: NEUROSCIENCE
10/09/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $13.76 General
Category: PSYCHIATRY
10/09/2024 Lilly USA, LLC AMYVID (Drug), KISUNLA Food and Beverage In-kind items and services $13.63 General
Category: Neuroscience
10/08/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $20.01 General
Category: BOTOX THERAPEUTIC

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 90 31,515 91,014 $6.9M $2.7M
2022 77 21,721 45,745 $3.5M $1.6M
2021 96 23,941 60,376 $4.7M $1.9M
2020 93 24,749 66,992 $4.0M $1.7M
Total Patients
101,926
Total Services
264,127
Medicare Billing
$7.9M
Procedure Codes
374

All Medicare Procedures & Services

374 procedure records from CMS Medicare Utilization — Page 1 of 15

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 1,359 10,225 $562,375 $416,765 74.1%
99458 Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes Office 2023 748 9,946 $978,686 $292,560 29.9%
99457 Management using the results of remote vital sign monitoring per calendar month, first 20 minutes Office 2023 748 4,973 $596,014 $181,092 30.4%
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days Office 2023 747 4,545 $587,123 $164,939 28.1%
99349 Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes Office 2023 443 1,488 $211,296 $140,773 66.6%
99309 Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes Facility 2023 456 1,760 $343,024 $139,028 40.5%
76536 Ultrasound scan of head and neck soft tissue Office 2023 486 963 $401,571 $80,152 20.0%
93925 Ultrasound of leg arteries or artery grafts Office 2023 443 450 $261,083 $80,063 30.7%
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 835 2,379 $102,297 $74,405 72.7%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Office 2023 515 523 $235,077 $74,225 31.6%
93880 Ultrasound of both sides of head and neck blood flow Office 2023 493 495 $229,523 $70,068 30.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 202 806 $161,050 $67,669 42.0%
93978 Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts Office 2023 483 486 $209,763 $64,869 30.9%
99348 Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes Office 2023 495 1,132 $108,672 $62,943 57.9%
82306 Vitamin d-3 level Office 2023 928 1,518 $60,720 $44,037 72.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 317 317 $47,550 $38,715 81.4%
82747 Folic acid level, rbc Office 2023 961 2,199 $82,946 $38,043 45.9%
84481 Thyroid hormone, t3 measurement, free Office 2023 975 2,260 $83,349 $37,516 45.0%
84443 Blood test, thyroid stimulating hormone (tsh) Office 2023 975 2,261 $82,753 $37,216 45.0%
84432 Thyroglobulin (thyroid related hormone) level Office 2023 975 2,260 $79,010 $35,572 45.0%
99448 Telephone or internet assessment with verbal and written report by consulting physician, 21-30 minutes Office 2023 418 843 $109,245 $34,471 31.6%
36410 Insertion of needle into vein (3 years or older) Office 2023 876 2,787 $69,675 $32,901 47.2%
82607 Cyanocobalamin (vitamin b-12) level Office 2023 961 2,199 $72,171 $32,501 45.0%
82728 Ferritin (blood protein) level Office 2023 961 2,199 $92,358 $29,379 31.8%
80061 Blood test, lipids (cholesterol and triglycerides) Office 2023 968 2,207 $64,356 $28,956 45.0%

About Dr. Imran Haque, M.D

Dr. Imran Haque, M.D is a Internal Medicine healthcare provider based in High Point, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134107022.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Imran Haque, M.D has received a total of $18,695 in payments from pharmaceutical and medical device companies, with $2,409 received in 2024. These payments were reported across 1,120 transactions from 87 companies. The most common payment nature is "Food and Beverage" ($18,428).

As a Medicare-enrolled provider, Haque has provided services to 101,926 Medicare beneficiaries, totaling 264,127 services with total Medicare billing of $7.9M. Data is available for 4 years (2020–2023), covering 374 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location High Point, NC
  • Active Since 01/03/2006
  • Last Updated 01/28/2026
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1134107022

Products in Payments

  • FARXIGA (Drug) $1,447
  • ENTRESTO (Drug) $870.63
  • Ozempic (Drug) $702.66
  • VRAYLAR (Drug) $597.43
  • MOUNJARO (Drug) $464.13
  • ARISTADA (Drug) $457.75
  • TRELEGY ELLIPTA (Drug) $438.14
  • JARDIANCE (Drug) $434.82
  • LONHALA MAGNAIR (Drug) $422.24
  • XARELTO (Drug) $410.69
  • UBRELVY (Drug) $374.30
  • AUSTEDO (Drug) $373.39
  • SYMBICORT (Drug) $322.40
  • TRULICITY (Drug) $321.49
  • INGREZZA (Drug) $304.71
  • QULIPTA (Drug) $297.62
  • ELIQUIS (Drug) $274.52
  • INVOKANA (Drug) $269.08
  • BREZTRI (Drug) $261.29
  • NUEDEXTA (Drug) $258.99

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in High Point